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Objective Assessment of the two year outcome of the Minitape™ procedure. 
 
Design  A prospective observational study of women undergoing the 
Minitape™ procedure for urodynamic stress incontinence. 
 
Setting Two tertiary referral urogynaecology units in the North of England. 
 
Population 60 women between November 2002 and March 2006. 
 
Methods Women attended a research clinic where they completed a standardised 
one hour pad test and were examined. Women were assessed pre-operatively and 
post-operatively at six months, one year and two years. 
 
Main Outcome Measures Success was determined by a negative one hour pad test 
(gain of less than one gram) and no desire for further treatment for stress urinary 
incontinence.  
 
Results All procedures were completed with local anaesthesia, with no 
additional sedation in 82% of cases. Intra-operative and immediate post-operative 
complications were rare. 12 women (20%) experienced mesh complications of which 
half were considered serious adverse events requiring exit from the study. At two 
years following Minitape™ insertion, 6 women (10%) were defined as cured.  
 
Conclusions Although feasible to perform, this procedure is associated with a 
substantially lower cure rate than previously published for other procedures. Cure 
rates decline over the two year follow up period, especially during the first six 
months. 
 
 
INTRODUCTION 
 
Stress urinary incontinence (SUI) in women is common and has a serious adverse 
effect on quality of life.  Although many procedures have been described for the 
treatment of USI, the insertion of a mid-urethral mesh tape, such as TVT (Tension-
free Vaginal Tape, Ethicon), has become standard practice with approximately 7000 
performed annually in England 1. 
 
Cure rates of over 80% have been reported for TVT 2-5 and the procedure avoids some 
of the operative morbidity associated with abdominal surgery such as the Burch 
colposuspension or fascial sling procedures. However, the needle introducers must 
pass through the retro-pubic space and exit through two small supra-pubic abdominal 
incisions. Intra-operative bladder, bowel, vascular and nerve injuries have been 
reported 5. 
 
The use of general or regional anaesthesia is now common however TVT was 
originally described as being performed under local anaesthesia with sedation. 
Although it is possible to insert the device utilising only local anaesthetic infiltration, 
a considerable volume is required to provide adequate anaesthesia along the route of 
the needle introducers. The use of sedation may lead to some women requiring an 
overnight hospital stay, reducing the number managed on a day-case basis. 
 
Miniaturisation of a tape, such that it may be inserted via a single, 1cm vaginal 
incision, may reduce the risk of intra-operative injury and reduce analgesic and 
anaesthetic requirements. Minitape™, Gyneideas, Glasgow, UK is a mid-urethral tape 
sling which is inserted through a single vaginal incision with no abdominal or groin 
exit incisions. The tape is a monocomponent, polypropylene mesh which is 200 
micrometres thick and 14 cm long. The needle introducer is approximately half the 
diameter of the TVT needle introducer (2.5mm diameter). A terminal anchor on each 
end of the tape fixes it in the retro-pubic space. 
 
This study was designed to determine the safety and efficacy of the Minitape™ 
procedure in the treatment of female stress urinary incontinence over a two year 
follow up period. A prospective, observational design was chosen given the lack of 
pre-existing clinical data on the device. Proof of safety and efficacy would then 
prompt randomised studies against established devices for the management of USI.  
 
 
MATERIALS AND METHODS 
 
Women having surgical treatment for urodynamic stress incontinence at two tertiary 
referral urogynaecology units in the North of England were recruited to the study 
between November 2002 and March 2006. A total of 60 women were included; 42 at 
site A (St Mary’s Hospital, Manchester) and 18 at site B (The Royal Victoria 
Infirmary, Newcastle). All women had found initial treatment with pelvic floor 
muscle training ineffective and were considering surgical treatment with a TVT. 
Inclusion and exclusion criteria for the study are provided in table 1. The study had 
approval from both the Central Manchester and the Newcastle and North Tyneside 
Research Ethics Committees. In addition, approval was granted by the hospitals’ 
department of research and development. All data were collected prospectively. 
  
 
Table 1: Study Inclusion and Exclusion Criteria. 
 
Inclusion Criteria Female patient aged 18 years or over 
 
 Urodynamic stress incontinence on multichannel urodynamics 
 
 No desire for future pregnancy 
 
 Able and willing to give informed consent 
 
Exclusion 
Criteria 
Detrusor over-activity 
 
 Pelvic organ prolapse requiring treatment 
 
 Post-micturition residual volume  >100mls 
 
 Maximum flow rate <15mls/sec with a voided volume of 
>150mls 
 
 Neurological disease 
 
 Anticoagulation therapy 
 
 Previous continence surgery 
 
 
Women were provided with verbal and written information with regard to the study 
protocol and gave their informed, written consent. The experimental nature of the 
device and the lack of efficacy data were clearly stated. Women were offered 
sedation. Utilising an aseptic technique and with the patient in the lithotomy position, 
local anaesthesia was infiltrated into the vaginal wall sub- and para-urethrally on each 
side. A 1cm  vaginal incision was made in the midline to allow introduction of the 
tape.  
 
The vaginal wound was closed with absorbable sutures following rigid, saline 
cystoscopy to exclude bladder and urethral injury. The bladder was then emptied and 
the patient was discharged when comfortable and voiding normally. Routine post-
operative catheterisation was not employed. All women were given a single dose of 
intravenous antibiotic prophylaxis during the procedure. 
 
Women attended for post-operative assessment at one month, six months, one year 
and two years. A standardised one hour pad test was performed at each visit. Cure 
was defined by a negative pad test (weight gain of less than one gram). Women 
requiring further treatment for USI, after confirmation on multichannel urodynamics, 
exited the study and were included in the ‘fail’ group. 
 
 
 RESULTS 
 
The mean age of women at the time of surgery was 52 years (range 32-81), the mean 
body mass index (BMI) was 28 (range 18-41.5) and the mean parity was 2 (range 0-
4). Complaints of chronic cough or constipation were reported by 33% of women. 
Other medical co-morbidities were found in 70% of women, including cardiovascular 
disease, chronic back pain and chronic obstructive airways disease.  
 
All women underwent pre-operative, multi-channel, urodynamic studies confirming 
the presence of urodynamic stress incontinence and normal voiding. 76% completed a 
standardised one hour pad test prior to surgery, with a mean increase in pad weight of 
31.7 grams.  
 
All procedures were completed under local anaesthesia, with only 11 women (18%) 
requiring sedation with intravenous Midazolam and Fentanyl. The mean duration of 
the procedure was 23.5 minutes (range 14-60 minutes). Immediate complications 
were rare. One woman had a button-hole tear of the vagina which was immediately 
repaired with no adverse effect on recovery. One woman sustained a hypodermic 
needle injury to the bladder during infiltration of the local anaesthesia. This was 
managed by urethral catheterisation overnight. Two further women required 
catheterisation post-operatively. 97% were voiding normally within 12 hours of the 
procedure and all were voiding normally within 32 hours with a mean of five hours 
(range 1-32 hours). 
 
Twenty six (43%) women required no post-operative analgesia with the remainder 
requiring simple oral analgesia only. There were no immediate post-operative 
complications and mean length of hospital stay was one day (range 0-5 days). One 
woman required planned hospitalisation for five days to receive post-operative 
haematological support for a known clotting disorder. 
 
Two women declined to attend any follow up appointments. Of the 58 who attended 
at one month post-operatively, urinary tract infection was identified in three women. 
Tape complications occurred in 12 women (20%) during the follow up period. Small 
filaments of tape extrusion through the vaginal epithelium occurred in three women. 
This was successfully managed by simple trimming of the mesh in the out-patient 
clinic, however, two of these women subsequently left the study requesting further 
continence surgery. A small area of asymptomatic vaginal mesh extrusion was 
identified in one woman at her two year visit. She elected not to have this trimmed. 
One woman developed a large area of vaginal mesh extrusion, considered to be a 
serious adverse event requiring exit from the study and removal of the tape. This was 
performed without complication and a TVT was inserted subsequently. Two women 
developed areas of mesh extrusion and had severe SUI requiring further continence 
surgery. They, therefore, left the study but did not exit primarily as a result of their 
tape complications. Five women experienced pain following insertion of the 
Minitape™. In four of these women, this was considered a serious adverse event 
requiring study exit and tape removal; in the fifth study exit had already been 
arranged as further continence surgery had been requested.   
 
One hour pad test results and associated cure rates are shown in table 2. Women who 
exited the study to undergo further continence surgery are included in the ‘fail’ group.   
 
Table 2: One Hour Pad Test Results. 
 
*Those women who had exited the study (to have further surgery, for example) and 
those who failed to attend their appointment are not included. 
 
Follow up Visit 
(months) 
1  6 12 24 
Number attending* 
 
58 47 31 19 
Number having pad test 
 
45 33 27 17 
Mean weight gain [grams] 
(range) 
10.1 
(0-103.1) 
17.3 
(0-90.3) 
12.6 
(0-147) 
2.4 
(0-9) 
Number defined as cured 
(% of total recruited) 
20 
(33) 
13 
(21) 
10 
(16) 
6 
(10) 
 
 
During the follow up period of the study a total of 23 women (38%) left the study for 
further surgical procedures for urodynamic stress incontinence. One woman 
underwent a fascial sling procedure, one woman underwent a transobturator tape; all 
other women had a TVT inserted. One woman exited the study for a planned TVT but 
deferred surgery due to family commitments. No intra-operative complications were 
experienced during the 22 procedures. Objective data with regard to cure following 
the second procedure were not collected as these women were no longer included in 
the study. However, subjective satisfaction was reported to be high.   
 
41 women exited the study prematurely. 3 women declined further visits during the 
follow up period and 9 were lost to follow up despite at least two invitations to attend. 
23 women left the study to undergo further continence surgery. 6 left the study 
following a serious adverse event, all of which were mesh complications requiring 
tape removal, as discussed above. 19 women completed the two year follow up 
period. 
 
 
DISCUSSION 
 
The insertion of a mid-urethral mesh tape has become standard practice for the 
surgical treatment of urodynamic stress incontinence (USI) in women. TVT™ is 
currently the most commonly used and has a high cure rate which is maintained over 
time, and associated with low surgical morbidity 4,5, 7-10. However, intra-operative 
visceral and vascular injury has been reported with the use of TVT, the most common 
bladder perforation occurring in 1 in 25 procedures 5. 
 
Meta-analysis of the available evidence confirms a lower risk of bladder injury 
utilising a trans-obturator route for tape insertion, with a relative risk of 6.14 for TVT 
compared to trans-obturator tape. However, the trans-obturator tapes may still be 
complicated by vaginal and urethral injury with a relative risk of urethral injury for 
TVT of 0.23 5. Although it is possible to insert both a TVT and trans-obturator tapes 
under local anaesthesia, most surgeons utilise additional sedation or perform the 
procedure under regional or general anaesthesia. 
 
Miniaturisation of a mid-urethral tape, such that it may be inserted via a single 
incision, has the potential to reduce intra-operative injury and anaesthetic and 
analgesic requirements. One such tape, TVT-Secur, Ethicon, has been available since 
2006. Although over 100,000 TVT-Secur devices have been sold worldwide there is 
little published data with regard to the safety or efficacy of single incision mesh slings 
for USI. The available data is currently limited to small case series utilising varied 
outcome measures and a short period of follow up 6. 
 
This study provides data of intra-operative safety and efficacy over a two year follow 
up period for a single incision mesh sling, the Minitape™. We have demonstrated that 
the insertion of such a device is a feasible procedure with no serious intra-operative 
complications occurring within the study. There were no cases of bladder perforation, 
by either the device or introducing needles, and no visceral or vascular injuries. A 
larger study would be required to confirm safety of the device, which is not 
appropriate given the level of efficacy demonstrated. 
 
Seven cases of mesh exposure occurred and, although four of these were successfully 
managed with little impact on patient recovery, this compares unfavourably with the 
rates of exposure reported for TVT. For example, Ward and Hilton, reporting on 
behalf of the UK and Ireland TVT Trial Group, reported only three vaginal exposures 
in 175 women, of which only one occurred within the first two years of follow up 4. In 
addition, five women experienced pain from the device, all of whom had the tape 
removed. This may be related to the terminal fixation zones at the end of the tape 
which anchor it in place. This area of the device was modified during the study to 
make it thinner and less rigid. All the adverse events related to pain from the device 
occurred in the early stages of the study, before the terminal fixation zones had been 
refined. Although alterations to the device make analysis of the resulting outcomes 
more difficult, such modifications were felt to be clinically necessary and reflected 
the evolution of such a novel device. It is not meaningful to examine the results of 
each generation of the device separately given the numbers involved. 
 
Rates of cure for TVT in the short term are high with reports of over 90% of women 
cured at one to two years following insertion 2, 12. Although longer term studies have 
demonstrated some reduction in the number of women cured over time, by five to 
seven years following TVT insertion cure rate remains between 70-80% 4,7-10. In this 
study, the rate of cure at one month was disappointing and rapidly declined such that 
it had dropped by one third by six months and halved by one year. It is unlikely that 
many women would accept a cure rate of 10% at two years despite the advantages 
provided by an ambulatory procedure with low intra-operative risk.  
 
The use of validated quality of life measures in the study of the efficacy of continence 
surgery is important. Although such data was collected prospectively during this 
study, analysis is not currently available. However, the relatively large number of 
women requesting additional continence surgery during the follow up period, suggests 
that this will reflect the objective results. 
 
The reasons for such a low cure rate can be debated. The surgeons (ARBS and PH) 
deliberately avoided placing the sling under tension as with the TVT. Anecdotally, 
protagonists of the other mini-slings have recommended placing such slings in close 
proximity to the urethra to compensate for any slippage during the convalescent 
period. This might result in a higher and more sustained cure rate than was achieved 
in this study. 
 
 
CONCLUSION 
 
We report the two year outcome data for the first 60 women who had a new single 
incision, mid-urethral sling (Minitape RP™) inserted. Although feasible to perform, 
this procedure is associated with a substantially lower rate of cure than other mid-
urethral tapes such as TVT. Rates of cure are also subject to rapid decline over the 
two year follow up period. Complications of the procedure were limited to mesh 
exposure. 
 
Whilst it may not be appropriate to extrapolate the results from this study to all 
miniaturised versions of the TVT, these results do indicate that such new tapes should 
undergo robust clinical evaluation before they are used outside the clinical trial 
setting. 
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 Erratum: 
(1)
 
 
1. North C, Hilton P, Ali-Ross N, Smith ARB.  Two year observational study to 
determine the efficacy of a novel single incision sling procedure (MiniTapeTM) for 
female stress urinary incontinence.  BJOG: Int J Obstet Gynaecol. 2010;117(3):356-
360. 
 
We would like to point out a number of errors in the above paper. 
1. We described the MiniTape as a monocomponent polypropylene mesh; this is 
inaccurate.  In fact there were four versions of the implanted device, the first 
being a solid planar polypropylene, the others having substantial solid 
polypropylene elements, with progressive introduction of central mesh.  The 
early design may have been critical to the high complication rate seen in this 
study, and may therefore not be generalisable to newer tape structures and 
designs. 
2. Gyne Ideas was the sole sponsor, contractor and legal manufacturer of this 
device.  Reference to Mpathy in our statement of funding and disclosure of 
interests is inaccurate. 
3. PH received research support from Gyne Ideas in the form of 2 years salary 
for a research nurse, and reimbursement of travel expenses to attend 
investigator meetings in connection with the study. 
4. We omitted to acknowledge the contribution of Dr James Browning MD, 
FRCOG, FRCSEd, MBA to this work.  The original concept of the minisling 
was uniquely his, and he contributed significantly to the conception and design 
of the study.   
 
